The ACLU is making its argument in federal court today against gene patenting, specifically against the BRCA1 and BRCA2 patents held by Myriad Genetics.
The ACLU is making its argument in federal court today against gene patenting, specifically against the BRCA1 and BRCA2 patents held by Myriad Genetics.
...and receive Daily News bulletins.
Already have a GenomeWeb or 360Dx account?
Login Now.
Don't have a GenomeWeb or 360Dx account?
Register for Free.